Round 1 Winners!
Proof of Usefulness Report

Mita AI Ltd.

Analysis completed on 3/12/2026

+79
Proof of Usefulness Score
You're In Business

The project addresses a highly relevant healthcare issue (cancer patient monitoring), but the submission contains severe red flags. Claims of audience reach ('everyone') and traction ('most people have used my product') are highly unrealistic for a specialized medical platform. Revenue metrics are incorrectly stated ('marketcap: 500000'), and technical details are vague. Due to the lack of verifiable evidence, contradictory statements, and poor response quality, the project receives a minimal score.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+62.5
Audience Reach Impact+0
Technical Innovation+15
Evidence Of Traction+0
Market Timing Relevance+15
Functional Completeness+0
Subtotal+92.5
Usefulness Multiplierx0.85
Final Score+79

Project Details

Project URL
Description
We are developing a platform to monitor cancer patients' mental and physical health in real-time and collect adherence data so that our AI-enabled system can help human to determine the cases requiring urgent intervention. The time-dependent patient data of physical and mental health will reduce the emergency hospital visits, reduce side-effect and increase the quality of life along of the patients and will deliver a significant efficiency improvement for the clinicians.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline